Glenmark recalls 6,528 bottles of blood pressure drug in US

As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Mb9vjKz
via IFTTT